Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of N91115 with Rifampin in Healthy Adults
NCT02500667Phase 1Completed
- Sponsor
- Nivalis Therapeutics
- Start
- Jun 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cavosonstat in cystic fibrosis (CF), sponsored by Nivalis Therapeutics. Primary endpoint: Area Under the Curve at Day 14. Started Jun 2015; status: completed.
02
Drugs
cavosonstat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02500667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02500667.